KR100348156B1 - 비브리오콜레래이01(cvd111)및비-01(cvd112와cvd112rm)혈청형백신균주,그것의제조방법및그것의생산물 - Google Patents

비브리오콜레래이01(cvd111)및비-01(cvd112와cvd112rm)혈청형백신균주,그것의제조방법및그것의생산물 Download PDF

Info

Publication number
KR100348156B1
KR100348156B1 KR1019960701669A KR19960701669A KR100348156B1 KR 100348156 B1 KR100348156 B1 KR 100348156B1 KR 1019960701669 A KR1019960701669 A KR 1019960701669A KR 19960701669 A KR19960701669 A KR 19960701669A KR 100348156 B1 KR100348156 B1 KR 100348156B1
Authority
KR
South Korea
Prior art keywords
cholerae
strain
sequence
gene
cholera toxin
Prior art date
Application number
KR1019960701669A
Other languages
English (en)
Korean (ko)
Other versions
KR960704571A (ko
Inventor
제임스 비. 카퍼
마이론 엠. 레반
Original Assignee
유니버시티 오브 매릴랜드 앳 발티모어
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 매릴랜드 앳 발티모어 filed Critical 유니버시티 오브 매릴랜드 앳 발티모어
Publication of KR960704571A publication Critical patent/KR960704571A/ko
Application granted granted Critical
Publication of KR100348156B1 publication Critical patent/KR100348156B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1019960701669A 1993-10-08 1994-10-07 비브리오콜레래이01(cvd111)및비-01(cvd112와cvd112rm)혈청형백신균주,그것의제조방법및그것의생산물 KR100348156B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13343893A 1993-10-08 1993-10-08
US13343993A 1993-10-08 1993-10-08
US08/133,439 1993-10-08
US08/133438 1993-10-08
US08/133439 1993-10-08
US08/133,438 1993-10-08

Publications (2)

Publication Number Publication Date
KR960704571A KR960704571A (ko) 1996-10-09
KR100348156B1 true KR100348156B1 (ko) 2003-01-06

Family

ID=26831377

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960701669A KR100348156B1 (ko) 1993-10-08 1994-10-07 비브리오콜레래이01(cvd111)및비-01(cvd112와cvd112rm)혈청형백신균주,그것의제조방법및그것의생산물

Country Status (8)

Country Link
EP (1) EP0722339A4 (ru)
JP (1) JP3379582B2 (ru)
KR (1) KR100348156B1 (ru)
CN (1) CN1104907C (ru)
AU (1) AU699912B2 (ru)
CA (1) CA2173606A1 (ru)
RU (1) RU2140981C1 (ru)
WO (1) WO1995010300A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0887403A3 (en) * 1997-06-27 2000-12-06 Chiron S.P.A. Attenuated Vibrio cholerae strains
EP0928831B1 (en) * 1997-12-10 2006-05-03 Council of Scientific and Industrial Research Cholera organisms, vaccines and preparation thereof
CN111826316A (zh) * 2020-07-28 2020-10-27 上海海洋大学 耐受重金属的非o1/o139型霍乱弧菌菌株及应用
CN111662855A (zh) * 2020-07-28 2020-09-15 上海海洋大学 耐受抗菌素和重金属的非o1/o139型霍乱弧菌菌株及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
AU656730B2 (en) * 1990-06-05 1995-02-16 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
JP4179627B2 (ja) * 1992-07-06 2008-11-12 プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ コレラワクチンとしての欠失変異体

Also Published As

Publication number Publication date
AU7971494A (en) 1995-05-04
EP0722339A1 (en) 1996-07-24
AU699912B2 (en) 1998-12-17
CA2173606A1 (en) 1995-04-20
WO1995010300A1 (en) 1995-04-20
CN1142774A (zh) 1997-02-12
KR960704571A (ko) 1996-10-09
EP0722339A4 (en) 2001-05-23
RU2140981C1 (ru) 1999-11-10
JP3379582B2 (ja) 2003-02-24
CN1104907C (zh) 2003-04-09
JPH09504430A (ja) 1997-05-06

Similar Documents

Publication Publication Date Title
US5631010A (en) Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1
US5399494A (en) Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
Nishibuchi et al. Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin
CA1335661C (en) Non-reverting shigella live vaccines
CA2244807A1 (en) Salmonella typhimurium vaccine
Guidolin et al. Genetics of Vibrio cholerae and its bacteriophages
US4935364A (en) Method of isolating restriction fragment deletions in vibrio cholerae and products thereof
HU225644B1 (en) Attenuated bacteria and vaccines containing thereof
EP0119031B1 (en) Avirulent Vibrio Cholerae and methods for its production
JP2004337175A (ja) 無毒性微生物及びその使用：サルモネラ
US5874088A (en) Deletion mutants of cholera vaccines expressing heterologous antigens
US5882653A (en) Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
KR100348156B1 (ko) 비브리오콜레래이01(cvd111)및비-01(cvd112와cvd112rm)혈청형백신균주,그것의제조방법및그것의생산물
JP3600618B2 (ja) Ｖｉｂｒｉｏ ｃｈｏｌｅｒａｅ中の制限酵素断片欠損の単離法およびその調製物
US5470729A (en) Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US5783196A (en) Gua mutants of shigella spp. and vaccines containing the same
JPH0630569B2 (ja) 遺伝子工学的に作成された無毒性Ｖｉｂｒｉｏ ｃｈｏｌｅｒａｅ、その用途及びその製造方法
Levine et al. 5.1 AN OVERVIEW OF CHOLERA PATHOGENESIS
EP0717774A1 (en) Production of gonorrheal pi proteins and vaccines in e. coli and salmonella

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee